Evidence map›Paper›PMID 27065775›Full record

ArticleEXCLI journal2016

A new assessment model for tumor heterogeneity analysis with [18]F-FDG PET images.

Ping Wang, Wengui Xu, Jian Sun, Chengwen Yang, Gang Wang, Yu Sa, Xin-Hua Hu, Yuanming Feng

Abstract read
In one paragraph

Article in EXCLI journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ping WangDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Wengui XuDepartment of Molecular Imaging and Nuclear Medicine, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Jian SunDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Chengwen YangDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; Department of Biomedical Engineering, Tianjin University, Tianjin, China.
Gang WangDepartment of Biomedical Engineering, Tianjin University, Tianjin, China.
Yu SaDepartment of Biomedical Engineering, Tianjin University, Tianjin, China.
Xin-Hua HuDepartment of Biomedical Engineering, Tianjin University, Tianjin, China; Department of Physics, East Carolina University, Greenville, NC.
Yuanming FengDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China; Department of Biomedical Engineering, Tianjin University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been shown that the intratumor heterogeneity can be characterized with quantitative analysis of the [18]F-FDG PET image data. The existing models employ multiple parameters for feature extraction which makes it difficult to implement in clinical settings for the quantitative characterization. This article reports an easy-to-use and differential SUV based model for quantitative assessment of the intratumor heterogeneity from 3D [18]F-FDG PET image data. An H index is defined to assess tumor heterogeneity by summing voxel-wise distribution of differential SUV from the [18]F-FDG PET image data. The summation is weighted by the distance of SUV difference among neighboring voxels from the center of the tumor and can thus yield increased values for tumors with peripheral sub-regions of high SUV that often serves as an indicator of augmented malignancy. Furthermore, the sign of H index is used to differentiate the rate of change for volume averaged SUV from its center to periphery. The new model with the H index has been compared with a widely-used model of gray level co-occurrence matrix (GLCM) for image texture characterization with phantoms of different configurations and the [18]F-FDG PET image data of 6 lung cancer patients to evaluate its effectiveness and feasibility for clinical uses. The comparison of the H index and GLCM parameters with the phantoms demonstrate that the H index can characterize the SUV heterogeneity in all of 6 2D phantoms while only 1 GLCM parameter can do for 1 and fail to differentiate for other 2D phantoms. For the 8 3D phantoms, the H index can clearly differentiate all of them while the 4 GLCM parameters provide complicated patterns in the characterization. Feasibility study with the PET image data from 6 lung cancer patients show that the H index provides an effective single-parameter metric to characterize tumor heterogeneity in terms of the local SUV variation, and it has higher correlation with tumor volume change after radiotherapy (R(2) = 0.83) than the 4 GLCM parameters (R(2) = 0.63, 0.73, 0.59 and 0.75 for Energy, Contrast, Local Homogeneity and Entropy respectively). The new model of the H index has the capacity to characterize the intratumor heterogeneity feature from 3D [18]F-FDG PET image data. As a single parameter with an intuitive definition, the H index offers potential for clinical applications.

Indexed as

[18]F-FDG PET imagegray level co-occurrence matrixintratumor heterogeneitystandard uptake value

Identifiers

PMID27065775
PMCPMC4822048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.